Genomics

Dataset Information

0

GLIDR-mediated Regulation of Tumor Malignancy and Cisplatin Resistance in Non-Small Cell Lung Cancer via the miR-342-5p/PPARGC1A Axis


ABSTRACT: LncRNAs play a crucial role in regulating the progression of NSCLC, making them potential targets for cancer diagnosis and treatment. Therefore, identifying new lncRNAs as therapeutic target and comprehending their underlying regulatory mechanisms are crucial for treating NSCLC. In this study, we found that glioblastoma down-regulated RNA (GLIDR) was increased in non-response NSCLC patients with the primary treatment, and GLIDR was also highly expressed in NSCLC patients. We used bioinformatic analysis and luciferase assays to identify that microRNA-342-5p (miR-342-5p) directly targets GLIDR. MiR-342-5p overexpression inhibits NSCLC cell proliferation, migration, and invasion, whereas miR-342-5p inhibition promotes NSCLC malignancy, which can be rescued by suppressing GLIDR. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PPARGC1A) was identified as a downstream target of miR-342-5p. PPARGC1A inhibition significantly suppresses NSCLC malignancy, whereas overexpression promotes it. The results also revealed that GLIDR overexpression reduced PPARGC1A inhibition by miR-342-5p, and increased PPARGC1A expression reversed the inhibition of NSCLC malignancies caused by decreased GLIDR. To the best of our knowledge, we are the first to discover that GLIDR promotes NSCLC progression by sponging miR-342-5p to regulate PPARGC1A expression, presenting that GLIDR act as a potential therapeutic target in NSCLC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE243455 | GEO | 2023/11/16

REPOSITORIES: GEO

Similar Datasets

2017-12-21 | GSE108324 | GEO
2021-12-15 | GSE178269 | GEO
2023-04-03 | GSE221334 | GEO
2021-10-13 | GSE171659 | GEO
2019-11-12 | PXD009845 | Pride
2022-08-10 | GSE206451 | GEO
2018-04-07 | GSE112804 | GEO
2024-04-10 | GSE255756 | GEO
| EGAD00001006844 | EGA
2023-06-06 | MODEL2305010001 | BioModels